You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR PERTOFRANE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for PERTOFRANE

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01478568 ↗	To Evaluate the Effect of Mirabegron (YM178) on Blood Levels of Desipramine When They Are Taken Together	Completed	Astellas Pharma Inc	Phase 1	2008-10-01	The study aims to evaluate if blood levels of desipramine change whilst being dosed at the same time with daily mirabegron.
NCT01719861 ↗	Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors	Terminated	Joel Neal	Phase 2	2012-10-01	Intrapatient dose escalation study of desipramine in subjects with small cell lung cancer (SCLC) and other high-grade neuroendocrine tumors.
NCT01899326 ↗	Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant	Completed	National Cancer Institute (NCI)	N/A	2012-12-01	This pilot clinical trial studies how well desipramine hydrochloride and filgrastim works for stem cell mobilization in patients with multiple myeloma undergoing stem cell transplant. Giving colony-stimulating factors, such as filgrastim, and other drugs, such as desipramine hydrochloride, helps stem cells move from the patient's bone marrow to the blood so they can be collected and stored.
NCT01899326 ↗	Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant	Completed	Albert Einstein College of Medicine	N/A	2012-12-01	This pilot clinical trial studies how well desipramine hydrochloride and filgrastim works for stem cell mobilization in patients with multiple myeloma undergoing stem cell transplant. Giving colony-stimulating factors, such as filgrastim, and other drugs, such as desipramine hydrochloride, helps stem cells move from the patient's bone marrow to the blood so they can be collected and stored.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for PERTOFRANE

Condition Name

Chart
Table

Condition Name for PERTOFRANE
Intervention	Trials
DS Stage I Plasma Cell Myeloma	1
DS Stage II Plasma Cell Myeloma	1
DS Stage III Plasma Cell Myeloma	1
Healthy Subjects	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for PERTOFRANE
Intervention	Trials
Neuroendocrine Tumors	1
Lung Neoplasms	1
Carcinoid Tumor	1
Neoplasms, Plasma Cell	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for PERTOFRANE

Trials by Country

Map
Table

Trials by Country for PERTOFRANE
Location	Trials
United States	2
France	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for PERTOFRANE
Location	Trials
New York	1
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for PERTOFRANE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for PERTOFRANE
Clinical Trial Phase	Trials
Phase 2	1
Phase 1	1
N/A	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for PERTOFRANE
Clinical Trial Phase	Trials
Completed	2
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PERTOFRANE

Sponsor Name

Chart
Table

Sponsor Name for PERTOFRANE
Sponsor	Trials
Astellas Pharma Inc	1
Joel Neal	1
National Cancer Institute (NCI)	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for PERTOFRANE
Sponsor	Trials
Other	3
Industry	1
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.